Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185
Author(s) -
P. O. Prada,
Eduardo R. Ropelle,
Rosa Helena Veras Mourão,
Cláudio Teodoro de Souza,
José Rodrigo Pauli,
Dennys E. Cintra,
André Almeida Schenka,
Silvana A. Rocco,
Roberto Rittner,
Kleber G. Franchini,
José Vassallo,
Lı́cio A. Velloso,
José Barreto Campello Carvalheira,
Mário J.A. Saad
Publication year - 2017
Publication title -
diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.219
H-Index - 330
eISSN - 1939-327X
pISSN - 0012-1797
DOI - 10.2337/db17-rt07a
Subject(s) - medicine , diabetes mellitus , endocrinology , insulin , tyrosine kinase , tyrosine kinase inhibitor , pharmacology , receptor , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom